Thyroidectomy Indications and Management

Diagnostic Approach

The American College of Radiology recommends ultrasound-guided FNA biopsy for large palpable nodules with smaller nodules present to definitively rule out malignancy, particularly for nodules >1-2 cm 1
The American Institute of Ultrasound in Medicine suggests risk stratification using TI-RADS scoring to quantify malignancy risk, with nodules classified as TI-RADS 4 or 5 requiring biopsy 2
Documentation of specific sonographic features such as microcalcifications, irregular margins, marked hypoechogenicity, and vascularity patterns is necessary to determine biopsy indications 1

The American Thyroid Association indicates that surgery is reserved for malignant/suspicious cytology, symptomatic compression, or documented progressive growth with concerning features 1
Indeterminate cytology with high-risk features, such as Bethesda III-IV nodules, may warrant surgery, though molecular testing can help refine this decision 1

The recommended management approach includes measuring serum TSH to confirm euthyroid status, performing high-resolution thyroid ultrasound with TI-RADS classification, and ultrasound-guided FNA biopsy of suspicious nodules 1, 2
If cytology is benign, observation with periodic follow-up ultrasound is recommended, while surgery is reserved for malignant/suspicious cytology, symptomatic compression, or documented progressive growth 1

The American Academy of Otolaryngology-Head and Neck Surgery notes that performing thyroidectomy without FNA confirmation carries significant risks, including unnecessary surgery for benign disease and surgical complications such as recurrent laryngeal nerve injury and hypoparathyroidism 3
The International Journal of Surgery suggests that emerging thermal ablation techniques may offer alternatives for symptomatic benign nodules, highlighting the importance of proper workup and diagnosis 4